GlobeNewswire: BBS-Bioactive Bone Substitutes Oyj Contains the last 10 of 309 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:31:17ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/06/2841128/0/en/Changes-in-BBS-Bioactive-Bone-Substitutes-Plc-s-Management-Team.html?f=22&fvtc=4&fvtv=44884Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team2024-03-06T09:15:00Z<![CDATA[BBS-Bioactive Bone Substitutes Plc, Company announcement, 6 March 2024 at 11:15 a.m.]]>https://www.globenewswire.com/news-release/2024/03/06/2841128/0/fi/Muutos-BBS-Bioactive-Bone-Substitutes-Oyj-n-johtoryhm%C3%A4ss%C3%A4.html?f=22&fvtc=4&fvtv=44884Muutos BBS-Bioactive Bone Substitutes Oyj:n johtoryhmässä2024-03-06T09:15:00Z<![CDATA[BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 6.3.2024 klo 11:15]]>https://www.globenewswire.com/news-release/2024/02/26/2835279/0/en/BBS-Bioactive-Bone-Substitutes-Plc-Financial-Statements-Bulletin-2023-Preparations-for-commercial-phase-initiated-unaudited.html?f=22&fvtc=4&fvtv=44884BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)2024-02-26T15:45:00Z<![CDATA[BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin 2023, 26 February 2024 at 5.45 p.m. (EET)]]>https://www.globenewswire.com/news-release/2024/02/26/2835279/0/fi/BBS-Bioactive-Bone-Substitutes-Oyj-Tilinp%C3%A4%C3%A4t%C3%B6stiedote-2023-Kaupallisen-vaiheen-valmistelut-alkaneet-tilintarkastamaton.html?f=22&fvtc=4&fvtv=44884BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 2023: Kaupallisen vaiheen valmistelut alkaneet (tilintarkastamaton)2024-02-26T15:45:00Z<![CDATA[BBS-Bioactive Bone Substitutes Oyj, Tilinpäätöstiedote, 26.2.2024 klo 17.45]]>https://www.globenewswire.com/news-release/2024/02/21/2832492/0/en/Inside-information-BBS-Bioactive-Bone-Substitutes-Plc-Drawdown-of-an-advance-pursuant-to-financing-arrangement-between-BBS-Bioactive-Bone-Substitutes-Plc-and-RiverFort-to-strengthe.html?f=22&fvtc=4&fvtv=44884Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position2024-02-21T08:30:00Z<![CDATA[BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 21 February 2024 at 10:30 am EET]]>https://www.globenewswire.com/news-release/2024/02/21/2832492/0/fi/Sis%C3%A4piiritieto-BBS-Bioactive-Bone-Substitutes-Oyj-on-sopinut-RiverFortin-kanssa-rahoitussopimuksen-mukaisen-ennakkomaksun-kolmannen-er%C3%A4n-nostamisesta-yhti%C3%B6n-k%C3%A4ytt%C3%B6p%C3%A4%C3%A4oman-vahvistam.html?f=22&fvtc=4&fvtv=44884Sisäpiiritieto - BBS-Bioactive Bone Substitutes Oyj on sopinut RiverFortin kanssa rahoitussopimuksen mukaisen ennakkomaksun kolmannen erän nostamisesta yhtiön käyttöpääoman vahvistamiseksi2024-02-21T08:30:00Z<![CDATA[BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, sisäpiiritieto, 21.2.2024 klo 10.30]]>https://www.globenewswire.com/news-release/2024/01/31/2821409/0/en/BBS-Bioactive-Bone-Substitutes-Plc-has-resolved-on-a-share-issue-without-consideration-to-the-company-itself.html?f=22&fvtc=4&fvtv=44884BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself2024-01-31T16:00:00Z<![CDATA[BBS-Bioactive Bone Substitutes Plc, Company announcement, 31 January 2024 at 6.00 p.m. EET]]>https://www.globenewswire.com/news-release/2024/01/31/2821409/0/fi/BBS-Bioactive-Bone-Substitutes-Oyj-on-p%C3%A4%C3%A4tt%C3%A4nyt-maksuttomasta-osakeannista-itselleen.html?f=22&fvtc=4&fvtv=44884BBS-Bioactive Bone Substitutes Oyj on päättänyt maksuttomasta osakeannista itselleen 2024-01-31T16:00:00Z<![CDATA[BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 31.1.2024 klo 18.00]]>https://www.globenewswire.com/news-release/2024/01/02/2802736/0/en/BBS-Bioactive-Bone-Substitutes-Plc-Kimmo-Tyni-appointed-as-Product-Director-of-BBS-Bioactive-Bone-Substitutes-Plc.html?f=22&fvtc=4&fvtv=44884BBS-Bioactive Bone Substitutes Plc: Kimmo Tyni appointed as Product Director of BBS-Bioactive Bone Substitutes Plc 2024-01-02T14:30:00Z<![CDATA[BBS-Bioactive Bone Substitutes Plc, Company Announcement, 2 January 2024 at 04.30 PM (EET)]]>https://www.globenewswire.com/news-release/2024/01/02/2802736/0/fi/BBS-Bioactive-Bone-Substitutes-Oyj-Kimmo-Tyni-nimitetty-BBS-Bioactive-Bone-Substitutes-Oyj-n-tuotantojohtajaksi.html?f=22&fvtc=4&fvtv=44884BBS-Bioactive Bone Substitutes Oyj: Kimmo Tyni nimitetty BBS-Bioactive Bone Substitutes Oyj:n tuotantojohtajaksi2024-01-02T14:30:00Z<![CDATA[BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 2.1.2024 klo 16.30]]>